Skip to main content
Future Journal of Pharmaceutical Sciences
Fig. 3 | Future Journal of Pharmaceutical Sciences

Fig. 3

From: In-silico and in-vitro analysis of novel substituted benzimidazolyl derivatives for antimycobacterial potentials targeting enoyl acyl carrier protein reductase (InhA)

Fig. 3

Protein–Ligand RMSD of lead compounds. Compound 4 = 3.2 & 5.2 Å, Compound 5a = 2.4 & 3.63 Å, Compound 5b = 3.2 & 4 Å; Compound 5c = 2.25 & 2.8 Å; Compound 5d = 2.4 & 4 Å; Compound 5e = 3.2 & 4 Å; Compound 5f = 3.2 & 3.6 Å

Back to article page